Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

MicroRNAs as Appropriate Discriminators in Non-Specific Alpha-Fetoprotein (AFP) Elevation in Testicular Germ Cell Tumor Patients.

Lembeck AL, Puchas P, Hutterer G, Barth DA, Terbuch A, Bauernhofer T, Pichler M.

Noncoding RNA. 2020 Jan 1;6(1). pii: E2. doi: 10.3390/ncrna6010002.

2.

Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.

Fischer S, Tandstad T, Cohn-Cedermark G, Thibault C, Vincenzi B, Klingbiel D, Albany C, Necchi A, Terbuch A, Lorch A, Aparicio J, Heidenreich A, Hentrich M, Wheater M, Langberg CW, Ståhl O, Fankhauser CD, Hamid AA, Koutsoukos K, Shamash J, White J, Bokemeyer C, Beyer J, Gillessen S; Global Germ-Cell Cancer Group.

J Clin Oncol. 2019 Dec 26:JCO1901876. doi: 10.1200/JCO.19.01876. [Epub ahead of print]

PMID:
31877087
3.

Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.

Terbuch A, Posch F, Bauernhofer T, Pichler M, Peinsith H, Szkandera J, Riedl J, Hutterer GC, Pummer K, Partl R, Kapp KS, Stöger H, Stotz M, Gerger A.

Anticancer Res. 2019 Oct;39(10):5589-5596. doi: 10.21873/anticanres.13753.

PMID:
31570454
4.

Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.

Moik F, Riedl JM, Winder T, Terbuch A, Rossmann CH, Szkandera J, Bauernhofer T, Kasparek AK, Schaberl-Moser R, Reicher A, Prinz F, Pichler M, Stöger H, Stotz M, Gerger A, Posch F.

Sci Rep. 2019 Apr 3;9(1):5548. doi: 10.1038/s41598-019-42069-1.

5.

MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.

Terbuch A, Adiprasito JB, Stiegelbauer V, Seles M, Klec C, Pichler GP, Resel M, Posch F, Lembeck AL, Stöger H, Szkandera J, Pummer K, Bauernhofer T, Hutterer GC, Gerger A, Stotz M, Pichler M.

Int J Mol Sci. 2018 Oct 12;19(10). pii: E3130. doi: 10.3390/ijms19103130.

6.

Correction to: Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).

Rothermundt C, Thurneisen C, Cathomas R, Müller B, Mingrone W, Hirschi-Blickenstorfer A, Wehrhahn T, Ruf C, Rothschild SI, Seifert B, Terbuch A, Grassmugg T, Woelky R, Fankhauser C, Kunit T, Fischer N, Inauen R, Kamradt J, Ziegler K, Haynes A, Jüni P, Gillessen S.

Swiss Med Wkly. 2018 Aug 29;148:w14674. doi: 10.4414/smw.2018.14674. eCollection 2018 Aug 27. No abstract available.

7.

Next Generation Cancer Vaccines-Make It Personal!

Terbuch A, Lopez J.

Vaccines (Basel). 2018 Aug 9;6(3). pii: E52. doi: 10.3390/vaccines6030052. Review.

8.

Baseline characteristics and patterns of care in testicular cancer patients: first data from the Swiss Austrian German Testicular Cancer Cohort Study (SAG TCCS).

Rothermundt C, Thurneysen C, Cathomas R, Müller B, Mingrone W, Hirschi-Blickenstorfer A, Wehrhahn T, Ruf C, Rothschild S, Seifert B, Terbuch A, Grassmugg T, Woelky R, Fankhauser C, Kunit T, Fischer N, Inauen R, Kamradt J, Ziegler K, Haynes A, Jüni P, Gillessen S.

Swiss Med Wkly. 2018 Jul 24;148:w14640. doi: 10.4414/smw.2018.14640. eCollection 2018. Erratum in: Swiss Med Wkly. 2018 Aug 29;148:w14674. Erratum.

9.

Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.

Terbuch A, Posch F, Partl R, Zurl B, Bauernhofer T, Pichler M, Szkandera J, Hutterer GC, Pummer K, Kapp KS, Stöger H, Gerger A, Stotz M.

Cancer Med. 2018 Feb;7(2):508-514. doi: 10.1002/cam4.1317. Epub 2018 Jan 19.

Supplemental Content

Loading ...
Support Center